Pembrolizumab and Olaparib in Cervical Cancer Patients
Immunotherapy in Combination With PARP Inhibition in Advanced Cervical Cancer Patients Functionally Competent or Deficient for the Fanconi Anemia Repair Pathway Immunotherapy in Combination With PARP Inhibition in Advanced Cervical Cancer Patients Functionally ...